A patient presents with low back pain. An MRI is ordered. The report comes back describing disc bulges, degenerative changes, and perhaps a small herniation. The assumption feels intuitive: there's the problem. But decades of research have revealed something that challenges this logic at its foundation.

Large studies of asymptomatic volunteers—people with no pain, no complaints, no clinical concern—consistently show high rates of the very same imaging abnormalities. Disc degeneration, meniscal tears, rotator cuff pathology, even brain white matter changes appear with striking frequency in people who feel perfectly fine.

This disconnect between what imaging reveals and what patients actually experience is one of the most important and underappreciated concepts in modern clinical medicine. Understanding it changes how we interpret scans, how we communicate findings to patients, and ultimately how we make treatment decisions that serve rather than harm.

The evidence here is both extensive and remarkably consistent. A landmark systematic review by Brinjikji and colleagues in 2015, published in the American Journal of Neuroradiology, examined spinal MRI findings across thousands of asymptomatic individuals. By age 50, approximately 80% had disc degeneration, 60% had disc bulges, and around 36% had disc protrusions. By age 70, over 95% showed degeneration. These were people with no back pain.

The spine is not an isolated case. Knee MRI studies tell a similar story. Research published in the New England Journal of Medicine found meniscal tears in 61% of asymptomatic adults over age 50. Shoulder imaging reveals partial rotator cuff tears in roughly 20-25% of people over 60 who have no shoulder complaints whatsoever. Brain MRI identifies incidental findings—white matter hyperintensities, silent infarcts, small aneurysms—in up to 20% of healthy adults undergoing screening scans.

What these figures reveal is that structural abnormality is, in many contexts, a feature of normal aging rather than a marker of disease. The human body accumulates wear. Discs lose hydration. Cartilage thins. Tendons develop microtears that remodel. These processes are nearly universal, and their presence on imaging does not reliably distinguish someone with symptoms from someone without.

This creates a fundamental challenge for clinicians. When an imaging finding is as common in the asymptomatic population as it is in the symptomatic one, its diagnostic value—its ability to identify the actual source of a patient's pain—diminishes substantially. The scan may be technically accurate in what it depicts, yet clinically misleading in what it implies.

Takeaway

An abnormality on a scan is not the same as a diagnosis. When the same findings appear in people without symptoms nearly as often as in those with them, the image alone cannot tell you what hurts or why.

The logical error at play is a familiar one in clinical reasoning: confusing correlation with causation. A patient has knee pain. Imaging shows a meniscal tear. It seems obvious that the tear explains the pain. But the high base rate of asymptomatic meniscal tears means that the tear may have been present before the pain began and may be entirely unrelated to it. The real source might be periarticular inflammation, referred pain, altered biomechanics, or central sensitization—none of which an MRI can see clearly.

Pain neuroscience has made this picture more complex and more honest. We now understand that pain is a multifactorial experience generated by the nervous system, influenced by tissue state but not determined by it alone. Psychosocial factors, sleep quality, stress levels, movement patterns, and prior pain experiences all modulate how—and whether—structural findings translate into symptoms. Two people with identical MRI reports can have vastly different clinical presentations.

There is also the problem of nocebo effects in imaging. Research has shown that the language used in radiology reports and the way findings are communicated to patients can itself worsen outcomes. Terms like "degeneration," "tear," and "herniation" carry alarming connotations. Patients who are told their spine shows degeneration may catastrophize, avoid movement, and develop chronic pain patterns that are driven more by fear and belief than by the structural finding itself.

None of this means that imaging findings are irrelevant. A large disc herniation compressing a nerve root with corresponding dermatomal weakness is a clinically meaningful correlation. The distinction lies in whether the imaging finding matches a specific, testable clinical pattern—or whether it is simply a finding in search of a symptom to explain.

Takeaway

A scan shows structure, not causation. Unless an imaging finding correlates precisely with a specific clinical pattern, it may be an incidental companion to your symptoms rather than the explanation for them.

The question clinicians should ask before ordering imaging is not "will we find something?" but "will what we find change what we do?" This principle—actionability—is central to evidence-based imaging decisions. Imaging is most valuable when it has a reasonable probability of revealing a finding that will alter the management plan: confirming a surgical candidate, ruling out a serious pathology like malignancy or fracture, or guiding an intervention to a specific anatomical target.

Clinical guidelines reflect this logic. For acute low back pain without red flags—no history of cancer, no progressive neurological deficit, no trauma suggesting fracture, no signs of infection—major guidelines from the American College of Physicians and the American College of Radiology recommend against routine imaging in the first six weeks. The reasoning is clear: early imaging in this population rarely identifies actionable pathology, frequently reveals incidental findings, and has been associated with increased rates of surgery, higher costs, and poorer patient satisfaction without improved outcomes.

Pre-test probability is the other essential concept. If a clinician has strong clinical suspicion for a specific pathology—say, an ACL rupture based on mechanism of injury, laxity testing, and joint effusion—then MRI serves to confirm a well-formed hypothesis. The finding is expected, specific, and directly linked to treatment planning. But when imaging is ordered as a fishing expedition in the absence of a clear clinical question, the likelihood of finding something incidental and clinically irrelevant rises sharply.

The framework, then, is straightforward: image when there is a specific clinical question that imaging can answer, when the answer will change management, and when the pre-test probability justifies the investigation. When these conditions are not met, imaging can introduce ambiguity, anxiety, and unnecessary intervention. Sometimes the most evidence-based decision is to leave the scanner off.

Takeaway

The value of a scan is not in what it finds but in whether what it finds changes what happens next. Imaging ordered without a clear clinical question often creates more problems than it solves.

Medical imaging is a powerful diagnostic tool, but its value depends entirely on context. A finding is only meaningful when it answers a clinical question, matches a specific symptom pattern, and leads to a management decision that would not have been made otherwise.

The high prevalence of structural abnormalities in asymptomatic populations is not a fringe observation—it is one of the most replicated findings in musculoskeletal and neurological research. Integrating this reality into clinical reasoning protects patients from unnecessary alarm, avoidable procedures, and the downstream consequences of overdiagnosis.

An abnormal scan does not necessarily mean something is wrong. And a normal clinical picture is not invalidated by an incidental finding. The evidence asks us to treat the patient, not the image.